Long-Term Iron Chelation Therapy with Deferiprone in Patients with Thalassemia Major and Low Iron Load

被引：1
|
作者：
Daar, Shahina [1 ]
Al-Khabori, Murtadha K. [2 ]
Al Farsi, Khalil [3 ]
Al-Rawahi, Bader Abdulla [1 ]
Al-Riyami, Arwa Z. [1 ,4 ]
机构：
[1] Sultan Qaboos Univ Hosp, Muscat, Oman
[2] Sultan Qaboos Univ Hosp, Dept Haematol, Muscat, Oman
[3] Sultan Qaboos Univ Hosp, Dept Haematol, Coll Med & Hlth Sci, Muscat, Oman
[4] Sultan Qaboos Univ Hosp, Al Khoud, Oman
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3626.3626
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3626
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major
    Unal, Sule
    Kalkan, Neslihan
    Cetin, Mualla
    Gumruk, Fatma
    BLOOD, 2016, 128 (22)
  • [32] Longitudinal Changes in Iron Overload Parameters and Iron Chelation Therapy in Young Patients with Thalassemia Major
    Kattamis, Antonis
    Stokidis, Konstantinos
    Delaporta, Polyxeni
    Dimitra, Kyriakopoulou
    Petropoulou, Theoni
    Boiu, Sorina
    Ladis, Vassilis
    BLOOD, 2011, 118 (21) : 1383 - 1383
  • [33] No progression of liver fibrosis in thalassemia major during deferiprone or desferrioxamine iron chelation.
    Piga, A
    Facello, S
    Gaglioti, C
    Pucci, A
    Pietribiasi, F
    Zimmermann, A
    BLOOD, 1998, 92 (10) : 21B - 21B
  • [34] Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
    Alavi, Samin
    Sadeghi, Elham
    Ashenagar, Azin
    BLOOD RESEARCH, 2014, 49 (01) : 72 - 73
  • [35] LONG-TERM EFFECTS OF LOW IRON BURDEN ON CLINICAL COURSE IN THALASSEMIA MAJOR
    COHEN, AR
    MARTIN, MB
    SCHWARTZ, E
    PEDIATRIC RESEARCH, 1989, 25 (04) : A149 - A149
  • [36] Deferasirox-Iron Complex Formation Ratio as an Indicator of Long-term Chelation Efficacy in β-Thalassemia Major
    Lu, Meng-Yao
    Lin, Ting-Hao
    Chiang, Po-Hung
    Kuo, Pei-Hsin
    Wang, Ning
    Wu, Wen-Hsin
    Lin, Kai-Hsin
    Wu, Tzu-Hua
    THERAPEUTIC DRUG MONITORING, 2017, 39 (02) : 185 - 191
  • [37] Effect of long-term iron chelation therapy with deferasirax on glucose metabolism of young patients with β-thalassaemia major
    Christoforidis, Athanasios
    Economou, Marina
    Teli, Aikaterini
    Tsatra, Ioanna
    Katzos, George
    HORMONE RESEARCH, 2009, 72 : 191 - 191
  • [38] Effective Iron Chelation Practice for Patients With β-Thalassemia Major
    Carson, Susan M.
    Martin, Marie B.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 (01) : 102 - 111
  • [39] Long term deferiprone chelation therapy
    Hoffbrand, VA
    Wonke, B
    IRON CHELATION THERAPY, 2002, 509 : 127 - 139
  • [40] Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
    Daar, S.
    Pathare, A. V.
    ANNALS OF HEMATOLOGY, 2006, 85 (05) : 315 - 319
12345